Back to Search
Start Over
Cross-Sectional Analysis of Adverse Dermatologic Events Reported to the FDA After Use of GLP-1 Agonists.
- Source :
-
Journal of drugs in dermatology : JDD [J Drugs Dermatol] 2024 Sep 01; Vol. 23 (9), pp. e181-e182. - Publication Year :
- 2024
- Subjects :
- Humans
United States epidemiology
Cross-Sectional Studies
Male
Female
Middle Aged
Adverse Drug Reaction Reporting Systems statistics & numerical data
Hypoglycemic Agents adverse effects
Hypoglycemic Agents administration & dosage
Glucagon-Like Peptide 1 agonists
Glucagon-Like Peptide 1 adverse effects
Diabetes Mellitus, Type 2 drug therapy
Glucagon-Like Peptide-1 Receptor agonists
Aged
Liraglutide adverse effects
Liraglutide therapeutic use
Exenatide adverse effects
Exenatide administration & dosage
Adult
Drug Eruptions etiology
Drug Eruptions epidemiology
United States Food and Drug Administration
Subjects
Details
- Language :
- English
- ISSN :
- 1545-9616
- Volume :
- 23
- Issue :
- 9
- Database :
- MEDLINE
- Journal :
- Journal of drugs in dermatology : JDD
- Publication Type :
- Editorial & Opinion
- Accession number :
- 39231072